Clinical efficacy of defibrase in treatment of acute ischemic cerebrovascular disease

Objective To analyze the clinical diagnosis and treatment of acute ischemic cerebrovascular disease (AICVD).Methods Three hundred and thirty cases of AICVD patients cured in our hospital during January 2010 to December 2011 were selected,and were randomly divided into observation group 170 cases and control group 160 cases,observation group were given intravenous infusion of defibrase,control group were given intravenous infusion of Compound Danshen,the clin ical efficacy of two groups were observed.Results The total effective rate of observation group was 93.53%,the total effec tive rate of control group was 81.87%,there was significant difference between the two groups (P 0.05);and compared with the control group,the plasma viscosity,high shear value,low shear value,fibrinogen,erythrocyte sedimentation rate of the observation group were lower,there was significant difference (P 0.05).Conclusion Intravenous infusion of defibrase can effectively prevente clotting and thrombosis,can achieve the purpose of treating AICVD,it is worthy of clinical practice.